UCSF’s pharmacogenetics program uses DNA testing to personalize prescriptions, reducing side effects and ensuring the right drug and dose for every patient.

Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular conditions. New evidence shows that the drugs may also protect against neurological diseases, like dementia, Parkinson's, and substance use disorder.

A large team of scientists, found that a single dose of psilocybin created positive changes in the brain and well-being, one hour and one month after administration.

UCSF Health is launching a special clinic for young adults with colorectal cancer, of which one in five cases now affects younger people, and is a leading cause of cancer death in people aged twenty to forty.

UCSF Health was named a top place to work by Becker's Healthcare.

A $2.5 million gift by Ted W. Love and Joyce Y. Love to UCSF Benioff Children’s Hospitals will expand care for patients with sickle cell disease and support the building of new facilities at the campus.

UCSF has received a $100 million commitment from longtime supporters Kathy Chiao and Kenneth Hao to address its most urgent capital needs and accelerate innovation to advance human health.

A team of researchers discover how the stentor, an organism made of a single, gigantic cell, learns without a brain.

A global team of scientists and clinicians found that a cheap, easy-to-use test for tuberculosis was just as good, if not better, at detecting disease than existing tests, shortening time to a diagnosis from days to just 15 minutes.

The American Association for the Advancement of Science, one of the world’s largest general scientific societies and publisher of the Science family of journals, named three UCSF faculty to the 2025 class of AAAS Honorary Fellows: Elissa Epel, Geeta Jayant Narlikar, and Donald Emil Ganem (emeritus).